Page last updated: 2024-11-07

bis(sulfosuccinimidyl)suberate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(sulfosuccinimidyl)suberate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123854
SCHEMBL ID43693
MeSH IDM0109367

Synonyms (31)

Synonym
bssis
1-[8-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-8-oxooctanoyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid
82436-77-9
BS3 ,
bs(3) cpd
disulfosuccinimidyl suberate
bis(sulfosuccinimidyl)suberate
e647932j7z ,
bis succinylsuberate bs(3)
unii-e647932j7z
3-pyrrolidinesulfonic acid, 1,1'-((1,8-dioxo-1,8-octanediyl)bis(oxy))bis(2,5-dioxo-
FT-0623095
AKOS015915978
octanedioic acid,1,8-bis(2,5-dioxo-3-sulfo-1-pyrrolidinyl) ester
SCHEMBL43693
bs3 crosslinker
bis(sulfosuccinimidyl) suberate
octanedioic acid, 1,8-bis(2,5-dioxo-3-sulfo-1-pyrrolidinyl) ester
bs-3
di(sulfosuccinimidyl) suberate
bis(sulphosuccinimidyl)suberate
VYLDEYYOISNGST-UHFFFAOYSA-N
bsss
Q4918484
mfcd01861948
1,1'-(octanedioylbis(oxy))bis(2,5-dioxopyrrolidine-3-sulfonic acid)
DTXSID801002683
1,1'-[(1,8-dioxooctane-1,8-diyl)bis(oxy)]bis(2,5-dioxopyrrolidine-3-sulfonic acid)
HY-124329
CS-0086215
bis[sulfosuccinimidyl] suberate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In dose-response curves the extent of the cytoskeletal association appears to follow the extent of bridging, continuing to increase beyond where stimulated degranulation is maximal."( Cross-linking of immunoglobulin E-receptor complexes induces their interaction with the cytoskeleton of rat basophilic leukemia cells.
Baird, B; Holowka, D; Robertson, D, 1986
)
0.27
" The dose-response curve for inhibition of covalent cross-linking of 125I-ANF by unlabeled ANF coincided with the dose-response curve for inhibition of binding to the receptor."( Affinity cross-linking of atrial natriuretic factor to its receptor in bovine adrenal zona glomerulosa.
Cantin, M; De Léan, A; Meloche, S; Ong, H, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (119)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (16.81)18.7374
1990's53 (44.54)18.2507
2000's16 (13.45)29.6817
2010's28 (23.53)24.3611
2020's2 (1.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.83 (24.57)
Research Supply Index4.79 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index35.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other119 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]